Archives: October 21 – 31, 2010
2010 Recent Advances in Internal Medicine — BLOG AVAILABLE ON NOVEMBER 1
Join physician-blogger Dr. Cynthia Christiano as she blogs about the nephrology-specific talks at the 2010 East Carolina University Recent Advances in Internal Medicine Conference.
Her blog is available by clicking here.
*** Note: Only registered users can participate in the virtual discussion. Not a registered user but interested in becoming one? Click here to complete our quick registration form.
SPRINT Trial — OPEN ENROLLMENT UNDERWAY
The Division of Nephrology and Hypertension at East Carolina University is now enrolling patients for the SPRINT Trial. The Systolic Blood PRessure INtervention Trial is an NIH-sponsored investigation to assess cardiovascular outcomes and all-cause mortality in patients randomized to intensive sBP control (< 120 mmHg) or standard sBP control (< 140 mmHg) over a 6-year followup period.
ECU is recruiting patients for this trial. To enroll your patient in the trial, please click here and complete a short questionnaire. A member of our research team will contact you with additional information.
Puzzle of the Week — PRIMARY HYPERALDOSTERONISM
- 1. 30% of all primary aldosterone cases have this
- 2. All confirmatory testing for the diagnosis of primary aldosteronism can be done safely only if this is repleted first
- 3. This drug class theoretically decreases levels of plasma renin activity (___-___)
- 4. The most common cause of secondary hypertension
- 5. Angiotensin-converting enzymes and angiotensin receptor blockers must be discontinued before administering the ARR screening test
- 6. The aldosterone:renin ratio is a type of ___ test
- 7. This phenomenom prevents edema from developing in patients with primary aldosteronism (___-___)
- 8. The absence of hypokalemia is a reliable indicator of not having primary aldosteronism
- 9. The type of hypertension that leads most physicians to perform screening tests for primary aldosteronism
- 10. This clinical entity presents very similarly to primary aldosteronism and can be ruled out by checking for urinary 18-hydroxycortisol (________-________-__________)
- 11. This drug class theoretically increases plasma renin activity
- 12. The next necessary step after an adrenal CT scan (____-___-_____)
- 13. Only mineralocorticoid-receptor antagonists and potassium-sparing diuretics must be discontinued prior to administering the aldosterone:renin screening test
- 14. Stroke, heart attacks, atrial fibrillation, and this are all increased in primary aldosterone patients than in any other etiology of hypertension
- 15. The time of day when the aldosterone:renin ratio should be performed for most accurate measurements
- 16. This group is more likely to suffer from hypokalemic periodic paralysis
- 17. PHysician who first mentioned a hypertensive patient with hypokalemia (mentioned in his 1954 presidential address at the Central Society for Clinical Research)
- No Times Recorded Yet
Abstract Submissions — UPDATED NOVEMBER 1, 2010
Keep your eyes on Nephrology On-Demand for more information on the following meetings:
International Forum on Quality and Safety in Healthcare 2011 — Abstract Deadline September 24, 2010